Species predicted to react based on 100% sequence homology:Monkey
Description
SignalSilence® Cbl-b siRNA II from Cell Signaling Technology (CST) allows the researcher to specifically inhibit Cbl-b expression using RNA interference, a method whereby gene expression can be selectively silenced through the delivery of double stranded RNA molecules into the cell. All SignalSilence® siRNA products from CST are rigorously tested in-house and have been shown to reduce target protein expression by western analysis.
Quality Control
Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
Directions for Use
CST recommends transfection with 100 nM SignalSilence® Cbl-b siRNA II 48 to 72 hours prior to cell lysis. For transfection procedure, follow protocol provided by the transfection reagent manufacturer. Please feel free to contact CST with any questions on use. Each vial contains the equivalent of 100 transfections, which corresponds to a final siRNA concentration of 100 nM per transfection in a 24-well plate with a total volume of 300 μl per well.
Background
The Casitas B lineage lymphoma (Cbl) proteins (in mammals these are c-Cbl, Cbl-b, and Cbl-c) are a family of single subunit RING finger protein-ubiquitin E3 ligases that contain multiple protein interaction motifs (1). All Cbl proteins have a highly conserved N-terminal tyrosine kinase-binding (TKB) domain that mediates interactions between Cbl proteins and phosphorylated tyrosine residues on Cbl substrates. C-terminal to the RING finger, Cbl proteins have proline-rich domains that mediate interactions with SH3 domain-containing proteins. Phosphorylated tyrosine residues mediate interactions with SH2 domain-containing proteins such as the p85 subunit of PI3K. These protein-protein interaction motifs allow Cbl family proteins to function as adaptor proteins (2). This adaptor function contributes to the E3-dependent activities of Cbl proteins by targeting specific substrates for ubiquitination and degradation. The adaptor function also contributes to non-E3-dependent activities, such as the recruitment of proteins involved in receptor tyrosine kinase internalization, localization of Cbl proteins to specific subcellular compartments, and activation of discrete signaling pathways (1).Cbl-b是一种E3泛素连接酶,具有与c-Cbl几乎相同的结构域。Cbl-b在造血细胞生理学的作用已经被报道。Cbl-b的表达对于抗原识别过程中TCR表达的下调很重要(2)。Cbl-b通过对PI3K的调节亚基p85的泛素化(3,4),实现CD28信号级联放大到Vav 和Rac1的负向调节作用。作为T淋巴细胞克隆无反应的一种重要的调节剂,Cbl-b mRNA和蛋白在钙动员和神经钙蛋白活化后,对T细胞进行增量调节(5)。Cbl-b缺乏的T细胞对无反应诱导有抵抗作用(5)。分子事件控制的这一表型被认为与PLCγ1和PKCθ泛素化作用有关,由于野生型无反应T细胞重新刺激后出现这些信号分子的降解,在Cbl-b缺乏的T细胞中并不出现(5)。